Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Canadian clearance for phase I study of SL-017 for acne and hair removal

Jan. 17, 2006

MRE-0094 enters phase II for chronic neuropathic diabetic foot ulcers

Jan. 13, 2006

Taclonex approved for psoriasis vulgaris

Jan. 11, 2006

Method for diagnosis/prognosis of wound infection claimed in Ethicon patent

Jan. 5, 2006

AN-0128: Potential antibacterial for a variety of dermatological infections

Jan. 3, 2006

Phase IIa study begins for topical PTH (1-34)

Jan. 2, 2006

Quest PharmaTech advances development of ACP-SL017

Dec. 28, 2005

New therapeutic agents for skin disorders disclosed in recent Galderma patent

Dec. 27, 2005

Clinical study of STA-5326 for psoriasis

Dec. 21, 2005

New therapeutic agents for skin disorders disclosed

Dec. 15, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...